The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. ICU Medical is the subject of an FDA warning letter published on April 22, 2025. According to the government agency, the Company "made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices." The FDA states that the Company's ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Eldorado Gold Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Class Action - Shareholders who purchased Eldorado Gold securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Eldorado Gold [2]. Group 2: Company Update and Stock Impact - On February 5, 2025, Eldorado Gold announced delays in the Skouries Project due to labor market tightness in Greece, which affected construction personnel availability [3]. - The company now expects first production at Skouries in Q1 2026 and commercial production by mid-2026 [3]. - Following this announcement, Eldorado Gold's stock price fell by $1.78 per share, or 11.2%, closing at $14.01 on February 6, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering investor losses [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Movado Group, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Allegations and Company Response - On April 11, 2025, Movado disclosed allegations of misconduct within its Dubai branch, related to sales practices in the Middle East, India, and Asia Pacific [3] - The company identified actions taken by the former managing director and certain employees that resulted in an overstatement of sales, premature recognition of sales, and underreporting of credit notes owed to customers [3] - Movado's financial statements dating back to 2022 will require restatements to accurately reflect sales and credits, indicating ineffective internal controls over financial reporting [3] Group 2: Stock Market Reaction - Following the news of the allegations, Movado's stock price fell to $13.56 per share, marking a 1.81% decrease from the previous closing price of $13.81 [3] Group 3: Legal Action and Investor Rights - Investors who purchased Movado Group securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses and encourages affected investors to join the action [2]

PHILADELPHIA, April 11, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) on behalf of purchasers of Rocket Lab securities between November 12, 2024 through February 25, 2025, inclusive (the "Class Period").Investor Deadline: Investors who purchased or acquired ROCKET LAB securities during the Class Period may, no later than APRIL 28, 2025, seek to be appointed as a lead ...

NEW YORK, April 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and August 29, 2024, both dates inclusive (the "Class Period"), of the important April 14, 2025 lead plaintiff deadline.So what: If you purchased Elastic securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To ...